Remove 2027 Remove Dosage Remove Vaccines
article thumbnail

HPAPI contract manufacturing to value $14.6 billion by 2030

European Pharmaceutical Review

However, during the second half, the surge in demand for vaccines to fight the coronavirus enhanced the industry’s need for raw materials and product intermediates of API molecules. However, due to the small volumes required for dosage, small-scale providers are also gaining importance, findings from the report show.

Dosage 105
article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

With the goal of supplying cell therapies, vaccines and other essential medicines such as antibody drugs to patients, the facilities aim to address major supply challenges and navigate the intricacies of producing fragile biological products. Subject to planning permission, the site is expected to be opened by 2028. Meath opened last month.